Cargando…
Topical Delivery of Senicapoc Nanoliposomal Formulation for Ocular Surface Treatments
Topical ophthalmologic treatments have been facing great challenges with main limitations of low drug bioavailability, due to highly integrative defense mechanisms of the eye. This study rationally devised strategies to increase drug bioavailability by increasing ocular surface residence time of dru...
Autores principales: | Phua, Jie Liang, Hou, Aihua, Lui, Yuan Siang, Bose, Tanima, Chandy, George Kanianthara, Tong, Louis, Venkatraman, Subbu, Huang, Yingying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213297/ https://www.ncbi.nlm.nih.gov/pubmed/30274277 http://dx.doi.org/10.3390/ijms19102977 |
Ejemplares similares
-
A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue
por: Hou, Aihua, et al.
Publicado: (2017) -
Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
por: Jin, Lee‐Way, et al.
Publicado: (2019) -
Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease
por: Bose, Tanima, et al.
Publicado: (2017) -
A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
por: Bose, Tanima, et al.
Publicado: (2017) -
Treatment with senicapoc in a porcine model of acute respiratory distress syndrome
por: Petersen, Asbjørn G., et al.
Publicado: (2021)